Anti-angiogenic targeted drugs

Clinical trials for Anti-angiogenic targeted drugs explained in plain language.

Never miss a new study

Get alerted when new Anti-angiogenic targeted drugs trials appear

Sign up with your email to follow new studies for Anti-angiogenic targeted drugs, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug cocktail targets brain tumors from lung and breast cancer

Disease control Cancelled

This Phase 2 trial tests a combination of two drugs, utidelone and bevacizumab, with or without a third drug called etoposide, in 56 patients with brain metastases from lung or breast cancer. The goal is to see if this treatment can shrink brain tumors and improve outcomes. Parti…

Matched conditions: ANTI-ANGIOGENIC TARGETED DRUGS

Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

Anti-angiogenic targeted drugs

Get alerted when new Anti-angiogenic targeted drugs trials appear

New drug cocktail targets brain tumors from lung and breast cancer